Business Wire

Dame Maggie Smith and Other Harry Potter Film Actors Join Jam City’s Harry Potter: Hogwarts Mystery

Jaa

Jam City:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180405005187/en/

Dame Maggie Smith as Professor McGonagall, in Harry Potter: Hogwarts Mystery from Jam City (Photo: B ...

Dame Maggie Smith as Professor McGonagall, in Harry Potter: Hogwarts Mystery from Jam City (Photo: Business Wire)

Who: Jam City, a Los Angeles based mobile games studio, in partnership with Warner Bros. Interactive Entertainment.

What:

  • Actors from the Harry Potter films will provide voiceover work for Jam City’s Harry Potter: Hogwarts Mystery. A full list of actors providing voice work for the game include:
    • Dame Maggie Smith (Professor McGonagall)
    • Michael Gambon (Professor Dumbledore)
    • Warwick Davis (Professor Flitwick)
    • Sally Mortemore (Madam Irma Pince)
    • Gemma Jones (Madam Pomfrey)
    • Zoe Wanamaker (Madam Hooch)
  • Global launch date for Harry Potter: Hogwarts Mystery confirmed to be Wednesday, April 25th on iOS and Android.

Where: Los Angeles, California

Quotes:
“If I could attend Hogwarts as a student, I would be most excited to attend the potions class taught by Severus because it is the most exotic,” said Dame Maggie Smith, voice of Professor McGonagall.

"Our goal with Harry Potter: Hogwarts Mystery is to make players really feel for the first time like they’re attending Hogwarts,” said Chris DeWolfe, co-founder and CEO of Jam City. “By including these iconic and incredibly talented actors in the game, we come one step closer to truly giving fans their own Hogwarts experience.”

Assets: To download supporting assets for Harry Potter: Hogwarts Mystery , please visit: https://app.box.com/v/HPHogwartsMystery-TalentReveal

Background: Harry Potter: Hogwarts Mystery is the first mobile game where players can create their own character and experience life as a Hogwarts student. In the narrative adventure with RPG elements, players will create a personalized student avatar, attend classes, learn magical skills, and form friendships or rivalries with other students. In the game, players make pivotal decisions that influence their character’s story arc at Hogwarts. The game features a new encounter system where player decisions and actions impact their quests, allowing Harry Potter fans to create their own legacy as a witch or wizard.

For more details on Harry Potter: Hogwarts Mystery and to connect with other fans, visit www.facebook.com/HPHogwartsMystery/, www.twitter.com/HogwartsMystery, and for more information visit www.HarryPotterHogwartsMystery.com/.

About Jam City:
Jam City is a global leader in mobile entertainment, providing social gaming experiences for millions of players around the world. Jam City was founded in 2010 by MySpace cofounders Chris DeWolfe and Aber Whitcomb, and former 20th Century Fox executive Josh Yguado. Jam City is the creative powerhouse behind some of the highest grossing and most enduring social gaming franchises for mobile, including Cookie Jam (Facebook “Game of the Year” winner) and Panda Pop. Jam City is the go-to studio for Hollywood, having developed immersive, narrative rich mobile games around iconic entertainment brands including Harry Potter, Family Guy, and Marvel Avengers. Jam City has 500 employees across studios in Los Angeles (HQ), San Francisco, San Diego, Seattle and Buenos Aires. The Jam City team is known for its creative excellence and technological innovation in key areas including storytelling, data science and consumer insights.

About Warner Bros. Interactive Entertainment:
Warner Bros. Interactive Entertainment, a division of Warner Bros. Home Entertainment, Inc., is a premier worldwide publisher, developer, licensor and distributor of entertainment content for the interactive space across all platforms, including console, handheld, mobile and PC-based gaming for both internal and third party game titles.

About Portkey Games:
Portkey Games, from Warner Bros. Interactive Entertainment, is a games label dedicated to creating Wizarding World™ gaming experiences inspired by the vision of J.K. Rowling. These new games allow players to explore, discover and be at the centre of their very own Wizarding World™ adventure.

About the Harry Potter Series:
Harry Potter continues to be a global phenomenon. Each of the seven books by author J.K. Rowling has broken sales records, with the series to date having sold over 500 million copies worldwide and translated into 80 languages. The Harry Potter films, produced by Warner Bros. Pictures, have grossed more than $7.7 billion to date worldwide at the box office, making Harry Potter one of the largest-grossing film franchises in history.

HARRY POTTER: HOGWARTS MYSTERY software © 2018 Jam City, Inc. Developed by Jam City. Jam City® and the Jam City Logo are registered and/or unregistered trademarks of Jam City, Inc. WIZARDING WORLD, HARRY POTTER and FANTASTIC BEASTS Publishing Rights © J.K. Rowling. PORTKEY GAMES, HARRY POTTER: HOGWARTS MYSTERY, WIZARDING WORLD, HARRY POTTER and FANTASTIC BEASTS characters, names and related indicia © and ™ Warner Bros. Entertainment Inc. All Rights Reserved

WB GAMES LOGO, WB SHIELD: ™ & © Warner Bros. Entertainment Inc. (s18)

Editor’s Note:
To download supporting assets for Harry Potter: Hogwarts Mystery , please visit: https://app.box.com/v/HPHogwartsMystery-TalentReveal

Contact information

Jam City
Sarah Ross, 310-924-1404
sarahr@jamcity.com
or
Kenny Johnston, 602-999-1890
kjohnston@jamcity.com
or
ONE PR Studio (for Jam City in the US)
Kjell Vistad | Gilberto Williams-Gamboa
510-893-3271
jamcity@oneprstudio.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting21.10.2018 01:30Tiedote

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent

Manchester United and True Religion Launch Denim Range19.10.2018 20:37Tiedote

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 16:10Tiedote

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 15:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an

Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 14:54Tiedote

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr

Tradeshift Announces Q3 2018 Results19.10.2018 14:00Tiedote

Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme